The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-transplant molecular minimal residual disease (MMRD) is associated with inferior outcomes in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
 
Muhammad Husnain
No Relationships to Disclose
 
Krishna Komanduri
Honoraria - Autolus; Incyte; Kadmon; Kiadis Pharma; Kite/Gilead; Novartis; Takeda
Consulting or Advisory Role - Autolus; Incyte; Kadmon; Kadmon; Kiadis Pharma; Kite/Gilead; Novartis; Takeda
Expert Testimony - Kite/Gilead
 
Jeremy Ramdial
No Relationships to Disclose
 
Lazaros J. Lekakis
Consulting or Advisory Role - Incyte; Janssen; Jazz Pharmaceuticals
 
Trent Peng Wang
No Relationships to Disclose
 
Mark Goodman
No Relationships to Disclose
 
Denise L. Pereira
Consulting or Advisory Role - Janssen Oncology; Jazz Pharmaceuticals
 
Amer Beitinjaneh
Consulting or Advisory Role - Kite, a Gilead company
Speakers' Bureau - Jazz Pharmaceuticals
Research Funding - Atara Biotherapeutics; Kite/Gilead
 
Douglas Carollo
No Relationships to Disclose
 
Robert Ali
No Relationships to Disclose
 
Yaqub Nadeem Mohammed
No Relationships to Disclose
 
Junaid Arshad
No Relationships to Disclose
 
Diana Byrnes
No Relationships to Disclose
 
Eduardo Edelman Saul
No Relationships to Disclose
 
Luis E. Aguirre
No Relationships to Disclose
 
Antonio Martin Jimenez
No Relationships to Disclose